Price Amy, Albarqouni Loai, Kirkpatrick Jo, Clarke Mike, Liew Su May, Roberts Nia, Burls Amanda
University of Oxford, UK.
Empower-2-Go, UK and USA.
J Eval Clin Pract. 2018 Feb;24(1):240-253. doi: 10.1111/jep.12805. Epub 2017 Oct 27.
Funders encourage lay-volunteer inclusion in research. There are controversy and resistance, given concerns of role confusion, exploratory methods, and limited evidence about what value lay-volunteers bring to research. This overview explores these areas.
Eleven databases were searched without date or language restrictions for systematic reviews of public and patient involvement (PPI) in clinical trials design. This systematic overview of PPI included 27 reviews from which areas of good and bad practice were identified. Strengths, weaknesses, opportunities, and threats of PPI were explored through use of meta-narrative analysis.
Inclusion criteria were met by 27 reviews ranging in quality from high (n = 7), medium (n = 14) to low (n = 6) reviews. Reviews were assessed using CERQUAL NICE, CASP for qualitative research and CASP for systematic reviews. Four reviews report risk of bias. Public involvement roles were primarily in agenda setting, steering committees, ethical review, protocol development, and piloting. Research summaries, follow-up, and dissemination contained PPI, with lesser involvement in data collection, analysis, or manuscript authoring. Trialists report difficulty in finding, retaining, and reimbursing volunteers. Respectful inclusion, role recognition, mutual flexibility, advance planning, and sound methods were reported as facilitating public involvement in research. Public involvement was reported to have increased the quantity and quality of patient relevant priorities and outcomes, enrollment, funding, design, implementation, and dissemination. Challenges identified include lack of clarity within common language, roles, and research boundaries, while logistical needs include extra time, training, and funding. Researchers report struggling to report involvement and avoid tokenism.
Involving patients and the public in clinical trials design can be beneficial but requires resources, preparation, training, flexibility, and time. Issues to address include reporting deficits for risk of bias, study quality, and conflicts of interests. We need to address these tensions and improve dissemination strategies to increase PPI and health literacy.
资助者鼓励让非专业志愿者参与研究。鉴于对角色混淆、探索性方法以及非专业志愿者给研究带来何种价值的证据有限等问题的担忧,存在争议和阻力。本综述探讨了这些领域。
检索了11个数据库,无日期或语言限制,以获取关于公众和患者参与(PPI)临床试验设计的系统评价。对PPI的这一系统综述纳入了27篇综述,从中确定了良好和不良实践领域。通过使用元叙事分析探讨了PPI的优势、劣势、机会和威胁。
27篇综述符合纳入标准,质量从高(n = 7)、中(n = 14)到低(n = 6)不等。使用CERQUAL NICE、定性研究的CASP和系统评价的CASP对综述进行评估。4篇综述报告了偏倚风险。公众参与的角色主要在议程设定、指导委员会、伦理审查、方案制定和试点方面。研究总结、随访和传播包含PPI,在数据收集、分析或稿件撰写方面的参与较少。试验者报告在寻找、留住和补偿志愿者方面存在困难。据报告,尊重性纳入、角色认可、相互灵活性、预先规划和合理方法有助于公众参与研究。据报告,公众参与增加了与患者相关的优先事项和结果的数量和质量、入组率、资金、设计、实施和传播。确定的挑战包括通用语言、角色和研究界限内缺乏清晰度,而后勤需求包括额外的时间、培训和资金。研究人员报告在报告参与情况和避免形式主义方面存在困难。
让患者和公众参与临床试验设计可能有益,但需要资源、准备、培训、灵活性和时间。需要解决的问题包括报告偏倚风险、研究质量和利益冲突方面的不足。我们需要解决这些矛盾并改进传播策略,以增加PPI和健康素养。